Summary: The Centers for Medicare & Medicaid Services modified its Adult Liver Transplantation coverage policy, effective May 15, 2026. Here's what billing teams need to know before that date.
CMS liver transplantation coverage policy changes carry serious financial weight. Adult liver transplantation is one of the highest-reimbursement procedures in Medicare, and any shift in medical necessity criteria, prior authorization requirements, or covered indications can mean the difference between a clean claim and a six-figure denial. This policy update applies to transplant programs and the hospitals billing Medicare for these services. The policy does not list specific CPT or HCPCS codes in the available data — we'll cover that in the Affected Codes section below.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Adult Liver Transplantation |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Transplant surgery, hepatology, hospital inpatient billing, transplant program administration |
| Key Action | Review your transplant program's documentation protocols and prior authorization workflows before May 15, 2026 |
CMS Adult Liver Transplantation Coverage Criteria and Medical Necessity Requirements 2026
The CMS adult liver transplantation coverage policy governs Medicare reimbursement for one of the most resource-intensive procedures in the program. This isn't a niche policy update — liver transplantation claims routinely exceed $300,000 per episode, and denials here don't get resolved with a simple appeal letter. You need the documentation right the first time.
CMS coverage for adult liver transplantation has historically required that the transplant be performed at a Medicare-approved transplant center. That approval isn't automatic. Centers must meet specific conditions of participation, and CMS monitors outcomes data closely. If your facility's approval status has lapsed or is under review, claims will deny regardless of how well the clinical documentation is structured.
Medical necessity for liver transplantation under CMS centers on end-stage liver disease or acute liver failure with a documented absence of contraindications. The standard clinical framework uses MELD (Model for End-Stage Liver Disease) scoring to establish severity. CMS expects documentation that shows the patient meets the clinical threshold and that alternative treatments have been exhausted or are not appropriate.
Prior authorization is not typically required for Medicare fee-for-service liver transplantation — but Medicare Advantage plans follow their own rules, and many require prior auth. If your transplant program serves Medicare Advantage beneficiaries, check each plan's individual requirements. Don't assume fee-for-service rules apply.
The coverage policy also addresses the approved indications. Covered diagnoses have historically included end-stage liver disease from causes such as cirrhosis (alcoholic, viral, or autoimmune), primary biliary cholangitis, primary sclerosing cholangitis, nonalcoholic steatohepatitis (NASH), hepatocellular carcinoma within Milan criteria, acute liver failure, and certain metabolic liver diseases. The key phrase is "within established criteria" — CMS doesn't cover transplantation for every liver condition, and documentation must clearly tie the diagnosis to the covered indication.
CMS Adult Liver Transplantation Exclusions and Non-Covered Indications
Not every patient with liver disease qualifies under the CMS coverage policy. Medicare does not cover liver transplantation when performed at a non-approved transplant center. That's the clearest exclusion, and it applies regardless of the patient's clinical status.
CMS also does not cover transplantation when active contraindications are present and undocumented or unaddressed. These include active substance abuse without demonstrated sobriety periods, uncontrolled psychiatric conditions, extrahepatic malignancy (with limited exceptions), and active systemic infections. The burden of documentation falls on the transplant team. If the record doesn't show that contraindications were evaluated and addressed, expect a denial or post-payment audit.
Hepatocellular carcinoma (HCC) coverage deserves special attention. CMS covers transplantation for HCC patients — but only when the tumor burden falls within the Milan criteria (single tumor ≤5 cm, or up to three tumors each ≤3 cm, with no vascular invasion or extrahepatic spread). Patients exceeding Milan criteria at the time of transplant are not covered under standard policy, though some downstaging protocols exist. Your transplant program's tumor board documentation needs to explicitly confirm Milan criteria compliance before listing and at the time of transplant.
Re-transplantation is also a nuanced area. CMS covers re-transplantation in specific clinical scenarios, but the medical necessity bar is high. Graft failure from primary non-function is more straightforward to document than re-transplantation for chronic rejection years after the original procedure. If your program performs re-transplants, make sure your documentation team knows what CMS expects to see.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| End-stage liver disease (cirrhosis — viral, alcoholic, autoimmune) | Covered | Policy does not list specific codes | Must be performed at CMS-approved transplant center; medical necessity documentation required |
| Primary biliary cholangitis / Primary sclerosing cholangitis | Covered | Policy does not list specific codes | MELD score and clinical trajectory must support transplant |
| Nonalcoholic steatohepatitis (NASH/NAFLD cirrhosis) | Covered | Policy does not list specific codes | Metabolic workup and contraindication clearance expected |
| Hepatocellular carcinoma within Milan criteria | Covered | Policy does not list specific codes | Tumor board documentation confirming Milan criteria compliance required |
| Hepatocellular carcinoma exceeding Milan criteria | Not Covered (standard) | Policy does not list specific codes | Downstaging protocols may apply; requires additional documentation |
| Acute liver failure | Covered | Policy does not list specific codes | High-urgency status must be supported by clinical record |
| Metabolic liver diseases (e.g., Wilson's disease, hereditary hemochromatosis) | Covered | Policy does not list specific codes | Disease-specific criteria apply; document irreversibility |
| Re-transplantation (primary non-function, acute rejection) | Covered | Policy does not list specific codes | High documentation bar; clinical necessity must be explicit |
| Transplant at non-approved CMS center | Not Covered | N/A | No exceptions; center approval is a prerequisite for reimbursement |
| Active contraindications present and unaddressed | Not Covered | N/A | Active substance abuse, extrahepatic malignancy, uncontrolled psychiatric conditions |
Note: This policy does not list specific CPT or HCPCS codes in the available data. See the Affected Codes section for guidance.
CMS Adult Liver Transplantation Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Confirm your transplant center's CMS approval status before May 15, 2026. Pull your facility's current approval documentation. If there's any lapse, renewal process, or pending survey, escalate to your compliance officer now. Claims billed after May 15 under a lapsed approval will deny. |
| 2 | Audit your medical necessity documentation templates. Every adult liver transplantation case billed to Medicare needs a clear documentation trail: diagnosis tied to a covered indication, MELD score (or equivalent severity measure), evidence that contraindications were evaluated, and confirmation of transplant center criteria. Review your current templates against what CMS expects. |
| 3 | Separate your Medicare Advantage billing workflows from fee-for-service. Prior authorization rules differ by plan. Build a checklist for your admissions and authorization team that flags Medicare Advantage cases for individual plan verification. Claim denial rates for transplant cases without proper prior auth documentation are high — and recovery is slow. |
| 4 | Document HCC cases with tumor board findings in the medical record. For every hepatocellular carcinoma transplant case, the Milan criteria assessment needs to be in the record and explicitly referenced in the transplant summary. "Within Milan criteria" as a phrase in the operative or transplant note is not enough — the actual tumor measurements and imaging findings need to be there. |
| 5 | Review re-transplantation documentation standards. If your program performs re-transplants, pull your last 12 months of claims and check how the medical necessity documentation is structured. Look at what your Medicare Administrative Contractor (MAC) has published on re-transplantation criteria. If you see gaps, fix the template before the May 15, 2026 effective date. |
| 6 | Brief your coding team on the policy modification. Even if the operational criteria haven't shifted dramatically, a policy modification is a trigger to re-verify that your coders know the current rules. Schedule a 30-minute coding review meeting before May 1, 2026. Cover covered indications, documentation requirements, and the distinction between Medicare fee-for-service and Medicare Advantage. |
| 7 | Talk to your compliance officer if you have unusual case mix. If your transplant program handles a significant volume of HCC downstaging cases, re-transplants, or metabolic disease transplants, the standard medical necessity documentation framework may not fully address your needs. Loop in your compliance officer and consider a pre-submission review process for complex cases. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Adult Liver Transplantation Under CMS Policy
A Note on Code Data
The CMS Adult Liver Transplantation policy, as captured in the available policy data, does not list specific CPT, HCPCS, or ICD-10 codes. This is not uncommon for CMS national coverage policies — the codes are often addressed in accompanying billing guidelines, transmittals, or local coverage determinations issued by Medicare Administrative Contractors.
Do not assume this means codes don't matter. Adult liver transplantation billing uses a defined set of procedure codes. Your MAC's local coverage determination and the CMS transmittals associated with this policy are the authoritative sources for the applicable code list.
What to Look For
Work with your coding team to verify the current procedure codes your program uses for adult liver transplantation — including the transplant procedure itself, back-table preparation, and donor organ acquisition where applicable. Also confirm the ICD-10-CM diagnosis codes your program uses for the covered indications listed above. Any mismatch between your current code set and what CMS's updated policy supports creates claim denial risk.
If you're not certain which codes your MAC recognizes under this policy, contact your MAC directly or check their published LCDs and billing guidelines. The Centers for Medicare & Medicaid Services also publishes transmittals that tie policy updates to specific code changes — search the CMS website using the policy title for the most current guidance.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.